Dantari Inc

Dantari Inc is a clinical stage biotechnology company based in Westlake Village, CA, dedicated to developing breakthrough therapies for the treatment of cancer and other serious diseases. Their proprietary Targeted High-capacity Drug Conjugate (T-HDC) platform enables the delivery of larger payloads with enhanced efficacy and safety compared to traditional chemotherapy and first-generation antibody-drug conjugates (ADCs).

With a focus on targeted therapeutics, Dantari's T-HDCs specifically target cancer cells and tumors, providing superior treatment profiles and a high drug-to-antibody ratio for greater efficacy. Their innovative platform technology allows for tunable release of therapeutic payloads, multi-valency, and evasion of the immune system, resulting in improved tumor accumulation and precision treatment. Currently, their pipeline includes T-HDC products for breast cancer and prostate cancer, with plans to expand into a wide range of indications in the future.

Generated from the website